Jens Lundgren

Jens Lundgren

Clinical Professor

Member of:

  • Internal medicine: infection medicine


  1. 2018
  2. Published

    Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals

    Peters, L., Laut, K., Resnati, C., Del Campo, S., Leen, C., Falconer, K., Trofimova, T., Paduta, D., Gatell, J., Rauch, A., Lacombe, K., Domingo, P., Chkhartishvili, N., Zangerle, R., Matulionyte, R., Mitsura, V., Benfield, T., Zilmer, K., Khromova, I., Lundgren, J. & 3 others, Rockstroh, J., Mocroft, A. & Eurosida Study Group, E. S. G., 2018, In: AIDS (London, England). 32, 14, p. 1995-2004 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study

    Peters, L., Mocroft, A., Grint, D., Moreno, S., Calmy, A., Jevtovic, D., Sambatakou, H., Lacombe, K., De Wit, S., Rockstroh, J., Smidt, J., Karpov, I., Grzeszczuk, A., Haziosmanovic, V., Gottfredsson, M., Radoi, R., Kuzovatova, E., Orkin, C., Ridolfo, A. L., Zapirain, J. & 1 others, Lundgren, Jens, 2018, In: Antiviral Therapy. 23, 5, p. 405-413 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study

    For the INSIGHT FLU003 Plus Study Group, F. T. I. F. P. S. G., 2018, In: Open Forum Infectious Diseases. 5, 1, 9 p., ofx228.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study

    Phillips, A. N., Cambiano, V., Nakagawa, F., Revill, P., Jordan, M. R., Hallett, T. B., Doherty, M., De Luca, A., Lundgren, J. D., Mhangara, M., Apollo, T., Mellors, J., Nichols, B., Parikh, U., Pillay, D., Rinke de Wit, T., Sigaloff, K., Havlir, D., Kuritzkes, D. R., Pozniak, A. & 6 others, van de Vijver, D., Vitoria, M., Wainberg, M. A., Raizes, E., Bertagnolio, S. & Working Group on Modelling Potential Responses to High Levels of Pre-ART Drug Resistance in Sub-Saharan Africa, W. G. O. M. P. R. T. H. L. O. P. D. R. I. S. A., 2018, In: The Lancet HIV. 5, 3, p. e146-e154

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Airflow limitation in people living with HIV and matched uninfected controls

    Ronit, A., Lundgren, Jens, Afzal, Shoaib, Benfield, Thomas, Roen, A., Mocroft, A., Gerstoft, Jan, Nordestgaard, Børge, Vestbo, J., Nielsen, S. D. & Copenhagen Co-morbidity in HIV infection (COCOMO) study group, C. C. I. H. I. (. S. G., 2018, In: Thorax. 73, 5, p. 431-438

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Associations between serum albumin and serious non-AIDS events among people living with HIV

    Ronit, A., Hatleberg, C. I., Ryom, L., Bonnet, F., El-Sadr, W., Reiss, P., Weber, R., Pradier, C., De Wit, S., Law, M., d'Arminio Monforte, A., Lundgren, Jens, Mocroft, A., Phillips, A. N., Sabin, C. A. & D:A:D Study Group, D. S. G., 2018, In: AIDS (London, England). 32, 13, p. 1837-1848 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Computed tomography quantification of emphysema in people living with HIV and uninfected controls

    Ronit, A., zwp671, zwp671, Hoseth, V. S., Abou-Kassem, D., Kühl, J. T., Benfield, Thomas, Gerstoft, Jan, Afzal, Shoaib, Nordestgaard, Børge, Lundgren, Jens, Vestbo, J., Kofoed, Klaus Fuglsang, Nielsen, S. D. & Copenhagen Comorbidity in HIV Infection (COCOMO) study group, C. C. I. H. I. (. S. G., 2018, In: The European Respiratory Journal. 52, 1, 9 p., 1800296.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study

    International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) Strategic Timing of Antiretroviral Treatment (START) Study Group, I. N. F. S. I. I. G. H. T. (. S. T. O. A. T. (. S. G., 2018, In: The Journal of Infectious Diseases. 217, 3, p. 405-412

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Hyaluronic Acid Is a Biomarker for Allograft Dysfunction and Predicts 1-Year Graft Loss After Liver Transplantation

    Rostved, A. A., Ostrowski, Sisse Rye, Peters, L., Lundgren, Jens, Hillingsø, Jens Georg, Johansson, P. I. & Rasmussen, A., 2018, In: Transplantation Proceedings. 50, 10, p. 3635-3643

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0

    the EACS Governing Board, T. E. G. B., 2018, In: HIV Medicine. 19, 5, p. 309-315 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 13961